Teva Sues Reckitt Over UK Generic-Drug Delay Tactics
Teva UK Ltd. has accused Reckitt Benckiser Group PLC of trying to thwart generic competition for its heartburn treatment by pulling one version of the drug from the country's official prescription...To view the full article, register now.
Already a subscriber? Click here to view full article